Mayet

What Mayet does

Mayet Solutions Ltd, founded in 2023 and headquartered in London with a distributed team across the United Kingdom, Spain, and Slovenia, sells software and advisory services for clinical trial vendor management and oversight. Its core product, VendorVigilance, is a cloud-deployed SaaS platform with eight integrated modules that provide audit-ready oversight of vendor portfolios from selection through study closure, built to comply with 21 CFR Part 11, ICH E6(R3), EudraLex Annex 11, and GDPR; the company also offers TrialTrack, a GxP-ready project management system with a free tier for small pharma and biotech teams. The technical stack runs on enterprise-grade cloud infrastructure with single-tenant and on-premise options, application-level encryption, customer-managed keys, near 100% automated test coverage, and quarterly dependency upgrades.

Mayet operates a hybrid professional services plus subscription business model. Advisory engagements are sold as fixed-fee packages (Assess up to £25,000, Design £35,000, Optimise £75,000) plus smaller offerings such as SOP Gap Analysis (£1,000) and an ICH E6(R3) Impact Seminar (£2,500), with up to 25% of advisory spend creditable toward an annual VendorVigilance subscription. Software revenue comes from VendorVigilance subscriptions (monthly or annual billing via Stripe) and the TrialTrack freemium conversion path; a modular pricing structure was introduced in April 2025. The go-to-market is CEO-led consultative sales targeting pharmaceutical sponsors, biotech companies, and CROs running GxP-regulated clinical studies, supported by a content-led marketing motion (blog, podcast, downloadable resources) and a partnership with Digital Quality Associates.

Name

Mayet

Legal name

Mayet Solutions Ltd

Website

https://mayetrx.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Mayet is a London-headquartered software and advisory company that provides VendorVigilance and TrialTrack, SaaS platforms for clinical trial vendor oversight and GxP-compliant project management, serving pharmaceutical sponsors, biotech companies, and CROs.

Ownership category

akta.pro rank

Product category

Clinical Trial Vendor Management Software

NAICS

Software Publishers (5132), Management Consulting Services (54161)

SIC

Services-Prepackaged Software (7372), Services-Management Consulting Services (8742)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industries

Clinical Trial Supply, Logistics & Vendor Management FSP (HLAGAOAH), Training & Competency Programs for GxP Compliance (HLAGAKAM)

Keywords

• Clinical trial software
• Vendor management platform
• GxP compliance software
• Vendor oversight solutions
• Clinical research advisory

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Vendor Consulting Advisory: Structured consulting programmes delivered by clinical research quality practitioners. Three main packages: Assess (up to £25,000), Design (£35,000), and Optimise (£75,000). Advisory spend credits toward VendorVigilance subscription (up to 25% of annual contract value each year). Additional smaller engagements include SOP Gap Analysis (£1,000) and ICH E6(R3) Impact Seminar (£2,500).
2. VendorVigilance SaaS Subscription: Annual subscription for the vendor management platform. Eight integrated modules for audit-ready vendor oversight. Advisory investment credits toward subscription. Paid plans billed monthly or annually through Stripe.
3. TrialTrack SaaS Subscription: GxP-compliant project management platform with free tier available. Paid features require subscription afterward. 14-day trial requires no payment method. Intended for small pharma and biotech teams.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Mayet provides software and advisory services for clinical trial vendor management and oversight targeting pharmaceutical sponsors, biotech companies, and CROs running GxP-regulated studies. Its core offerings are VendorVigilance, an audit-ready vendor oversight SaaS platform with eight integrated modules covering vendor portfolios from selection through study closure, and TrialTrack, a GxP-ready project management system with a free tier for small pharma and biotech teams. These software products are complemented by Vendor Consulting, structured advisory programmes led by CEO Tom Lazenby that include Assess, Design, and Optimise packages, where advisory spend credits toward a VendorVigilance subscription to drive software adoption.

Product overview

Mayet offers a platform-plus-advisory model combining purpose-built software with hands-on consulting services for clinical vendor oversight. The core software portfolio includes VendorVigilance, an audit-ready vendor oversight platform with eight integrated modules for managing vendor portfolios across the full study lifecycle, and TrialTrack, a GxP-ready project management system for clinical teams. These are complemented by Vendor Consulting advisory programmes that deliver structured consulting for organizations needing to strengthen processes before adopting software, with advisory spend creditable against VendorVigilance subscriptions.

Differentiator

Problem solved

Functional benefit

Brands

• VendorVigilance: Audit-ready vendor oversight platform for pharmaceutical sponsors and CROs managing clinical vendor portfolios. Full visibility across vendor portfolio from selection through study closure, with eight integrated modules and 21 CFR Part 11 compliance.
• TrialTrack

Products and services

• VendorVigilance Audit-ready vendor oversight platform providing full visibility across vendor portfolios from selection through study closure. Features eight integrated modules and 21 CFR Part 11 compliance, engineered for ICH E6(R3) alignment, and used by pharmaceutical sponsors, biotech companies, and CROs.
• TrialTrack GxP-ready project management system for small pharma and biotech teams managing studies, sites, and participants. Offers compliance built in from day one with no enterprise CTMS cost or complexity, with a free tier available and 14-day trial that does not require a payment method.
• Vendor Consulting Advisory programmes for clinical QA led by Tom Lazenby, including Assess (up to £25,000), Design (£35,000), and Optimise (£75,000) packages, plus smaller engagements (SOP Gap Analysis £1,000, ICH E6(R3) Impact Seminar £2,500). Advisory spend credits toward a VendorVigilance subscription up to 25% of annual contract value each year.

Quantifiable outcome

• Average cost of regulatory inspection finding for clinical trial sponsor: $1.8 million (Tufts Center for the Study of Drug Development)
• +2 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• PHARMASEALcoreTechnology or Integration · 9 April 2025Integration partnership connecting Mayet's vendor management platform with PHARMASEAL CTMS (Clinical Trial Management System). Enables connection between vendor oversight and clinical trial management in one unified platform. Announced April 9, 2025.
• Digital Quality Associates (DQA)coreStrategic or Co-development PartnerStrategic partnership with DQA, an independent quality assurance consultancy specializing in healthcare, biotech, and medical devices. DQA provides compliance and validation support to both Mayet and its clients, ensuring regulatory requirements are addressed from earliest stages of product development. DQA consultants accompany Tom Lazenby on advisory engagements.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• PHARMASEAL: CTMS provider with which Mayet has a direct integration partnership. Operates in the same clinical trial management space serving small and mid-sized sponsors and CROs with adjacent workflows.
• Florence Healthcare: Provider of eRegulatory and eISF solutions for clinical trial sites and sponsors. Comparable focus on enabling clinical operations compliance through purpose-built software for research sites.
• Bio-Optronics: Clinical trial management software vendor serving sponsors and CROs with CTMS, scheduling, and operational tools. Comparable in targeting mid-market clinical operations teams with focused software.
• RealTime Software Solutions: Provider of CTMS, eDOCS, and payment solutions for clinical research sites and sponsors. Comparable in serving the operational backbone of clinical trial execution with compliance-grade software.

Broad incumbents

• ArisGlobal: Life sciences technology vendor covering regulatory, safety, and clinical workflows. Comparable in serving GxP-regulated functions with a platform approach that competes against Mayet's point solution.
• Medidata (Dassault Systèmes): Industry-leading clinical trial technology platform offering CTMS, EDC, and analytics for pharma and CROs. Represents the broad-platform alternative to Mayet's specialized vendor oversight offering.
• Veeva Systems: Dominant cloud software provider for life sciences with Veeva Vault CTMS and broader clinical operations suite. Mayet competes as a specialized vendor oversight layer that must coexist with or integrate into Veeva's stack.
• Oracle Clinical One: Oracle's clinical trial platform spanning EDC, CTMS, and RTSM. Represents a deep-pocketed incumbent alternative that could add or extend vendor oversight capabilities against Mayet's positioning.
• IQVIA Technologies: IQVIA's clinical technology portfolio including CTMS and operational analytics, backed by the world's largest CRO. Represents a scale competitor with both advisory and software offerings that could pressure Mayet's value proposition.
• Clario: Clinical trial technology company offering eCOA, imaging, and endpoint adjudication services. Broad incumbent in clinical operations technology that intersects with Mayet's regulatory-grade positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mayetrx

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mayet